Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.

The leukemic B lymphocytes from chronic lymphocytic leukemic (CLL) patients have a long survival in vivo, although ex vivo they rapidly die by apoptosis. To further investigate the mechanism of this, we have studied the influence of bone marrow stromal cells from normal subjects on apoptosis of B-CLL cells and normal umbilical cord blood (UCB) B lymphocytes. After 48 hours of incubation in medium alone, leukemic and normal B cells showed, respectively, 22 +/- 3% and 31 +/- 5% of apoptosis. Cocultures with stromal cells reduced the percentage of leukemic cells undergoing apoptosis (8 +/- 2%, P < . 0005) and prevented the loss of bcl-2 protein expression. In contrast, stromal cells slightly increased normal B-cell apoptosis (37 +/- 6%). Direct contact between leukemic cells and stromal cells was found to be essential for inhibition of leukemic cell apoptosis; indeed, separation of leukemic cells from stromal cells by microporous membrane increased spontaneous apoptosis, and comparable results were obtained with stromal cell conditioned medium. The difference in behavior observed between normal and leukemic B cells plated on stromal cells can be explained by the fact that only a few normal B cells adhere to stromal cells in comparison with B-CLL cells. B-CLL cell adhesion to stromal cells is mediated by beta1 and beta2 integrins acting simultaneously. Contact between B-CLL cells and bone marrow stromal cells seems to play a major role in the accumulation and survival of B-CLL cells in the bone marrow.

[1]  A. Minty,et al.  Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. , 1996, Blood.

[2]  F. Behm,et al.  Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. , 1994, Blood.

[3]  J. Liesveld,et al.  Maturation-dependent adhesion of human B cell precursors to the bone marrow microenvironment. , 1990, Journal of immunology.

[4]  I. Katayama,et al.  Surface phenotype and adhesion activity of B-cell chronic lymphoid leukemias. , 1993, Leukemia & lymphoma.

[5]  J. Banchereau,et al.  Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells , 1994, The Journal of experimental medicine.

[6]  J. H. Pope,et al.  Spontaneous programmed death (apoptosis) of B‐chronic lymphocytic leukaemia cells following their culture in vitro , 1989, British journal of haematology.

[7]  S. Tangye,et al.  Leukaemic CD5+ B‐cell apoptosis: co‐incidence of cell death and DNA fragmentation with reduced bcl‐2 expression , 1996, British journal of haematology.

[8]  H. Bernstein,et al.  Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. , 1995, Leukemia & lymphoma.

[9]  C. Verfaillie,et al.  Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. , 1992, Blood.

[10]  V. Quesniaux,et al.  Human B-lymphopoiesis is supported by bone marrow-derived stromal cells. , 1991, Experimental hematology.

[11]  V. Fadok,et al.  Apoptosis and programmed cell death in immunity. , 1992, Annual review of immunology.

[12]  P. Lydyard,et al.  Interferon‐alpha up‐regulates bcl‐2 expression and protects B‐CLL cells from apoptosis in vitro and in vivo , 1994, British journal of haematology.

[13]  D. Campana,et al.  Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia , 1993, The Journal of experimental medicine.

[14]  R. Bates,et al.  Involvement of integrins in cell survival , 1995, Cancer and Metastasis Reviews.

[15]  J. Banchereau,et al.  Culture of human fetal B-cell precursors on bone marrow stroma maintains highly proliferative CD20dim cells. , 1993, Blood.

[16]  G. Abraham,et al.  Apoptosis and interleukin 7 gene expression in chronic B-lymphocytic leukemia cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  W. Newman,et al.  Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. , 1994, Journal of immunology.

[18]  G. Pizzolo,et al.  In leukaemic CD5+ B cells the expression of BCL‐2 gene family is shifted toward protection from apoptosis , 1996, British journal of haematology.

[19]  I. Maclennan,et al.  Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl‐2 induction , 1993, European journal of immunology.

[20]  L. Lagneaux,et al.  Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production. , 1993, Blood.

[21]  K. Bradstock,et al.  Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma. , 1996, Leukemia.

[22]  G. Delespesse,et al.  Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression , 1992, The Journal of experimental medicine.

[23]  T. McDonnell,et al.  Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. , 1996, Leukemia.

[24]  G. Núñez,et al.  Stromal cells regulate bcl-2 and bax expression in pro-B cells. , 1996, Experimental hematology.

[25]  S. Orrenius,et al.  Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. , 1991, Journal of immunology.

[26]  J. Burthem,et al.  Integrin function in chronic lymphocytic leukemia. , 1996, Blood.

[27]  W. Dameshek.  Special Article: Chronic Lymphocytic Leukemia—an Accumulative Disease of Immunologically Incompetent Lymphocytes , 1967 .

[28]  S. Kamel‐Reid,et al.  Engraftment of human chronic lymphocytic leukemia cells in SCID mice: in vivo and in vitro studies. , 1996, Leukemia.

[29]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[30]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[31]  L. Foroni,et al.  Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro , 1996, British journal of haematology.

[32]  A. Prentice,et al.  Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4. , 1994, Blood.

[33]  J. Gimble,et al.  Cells and molecules that regulate B lymphopoiesis in bone marrow. , 1989, Annual review of immunology.

[34]  J. Greenberger,et al.  Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. , 1992, The Journal of clinical investigation.

[35]  T. Dexter,et al.  Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis , 1990, Nature.

[36]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[37]  A. Fischer,et al.  Phenotypic and functional characteristics of human newborns' B lymphocytes. , 1990, Journal of immunology.

[38]  A. Novarino,et al.  The nature of the B lymphocyte in B-chronic lymphocytic leukemia. , 1993, Blood cells.

[39]  T. McDonnell,et al.  Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. , 1996, Journal of immunology.